• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硬蛋白冠和软蛋白冠的互补分析:样品制备对冠层组成有至关重要的影响。

Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.

作者信息

Winzen S, Schoettler S, Baier G, Rosenauer C, Mailaender V, Landfester K, Mohr K

机构信息

Max Planck Institute of Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.

出版信息

Nanoscale. 2015 Feb 21;7(7):2992-3001. doi: 10.1039/c4nr05982d.

DOI:10.1039/c4nr05982d
PMID:25599336
Abstract

Here we demonstrate how a complementary analysis of nanocapsule-protein interactions with and without application media allows gaining insights into the so called hard and soft protein corona. We have investigated how both human plasma and individual proteins (human serum albumin (HSA), apolipoprotein A-I (ApoA-I)) adsorb and interact with hydroxyethyl starch (HES) nanocapsules possessing different functionalities. To analyse the hard protein corona we used sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and a protein quantitation assay. No significant differences were observed with regards to the hard protein corona. For analysis of the soft protein corona we characterized the nanocapsule-protein interaction with isothermal titration calorimetry (ITC) and dynamic light scattering (DLS). DLS and ITC measurements revealed that a high amount of plasma proteins were adsorbed onto the capsules' surface. Although HSA was not detected in the hard protein corona, ITC measurements indicated the adsorption of an HSA amount similar to plasma with a low binding affinity and reaction heat. In contrast, only small amounts of ApoA-I protein adsorb to the capsules with high binding affinities. Through a comparison of these methods we have identified ApoA-I to be a component of the hard protein corona and HSA as a component of the soft corona. We demonstrate a pronounced difference in the protein corona observed depending on the type of characterization technique applied. As the biological identity of a particle is given by the protein corona it is crucial to use complementary characterization techniques to analyse different aspects of the protein corona.

摘要

在这里,我们展示了对有无应用介质时纳米胶囊 - 蛋白质相互作用进行补充分析,如何有助于深入了解所谓的硬蛋白冠层和软蛋白冠层。我们研究了人血浆以及单个蛋白质(人血清白蛋白(HSA)、载脂蛋白A - I(ApoA - I))如何吸附到具有不同功能的羟乙基淀粉(HES)纳米胶囊上并与其相互作用。为了分析硬蛋白冠层,我们使用了十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS - PAGE)和蛋白质定量测定法。在硬蛋白冠层方面未观察到显著差异。对于软蛋白冠层的分析,我们用等温滴定量热法(ITC)和动态光散射(DLS)对纳米胶囊 - 蛋白质相互作用进行了表征。DLS和ITC测量结果表明,大量血浆蛋白吸附到了胶囊表面。虽然在硬蛋白冠层中未检测到HSA,但ITC测量表明有与血浆中含量相似的HSA以低结合亲和力和反应热被吸附。相比之下,只有少量ApoA - I蛋白以高结合亲和力吸附到胶囊上。通过这些方法的比较,我们确定ApoA - I是硬蛋白冠层的一个组分,而HSA是软蛋白冠层的一个组分。我们证明,根据所应用的表征技术类型,观察到的蛋白冠层存在显著差异。由于颗粒的生物学特性由蛋白冠层决定,因此使用互补的表征技术来分析蛋白冠层的不同方面至关重要。

相似文献

1
Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.硬蛋白冠和软蛋白冠的互补分析:样品制备对冠层组成有至关重要的影响。
Nanoscale. 2015 Feb 21;7(7):2992-3001. doi: 10.1039/c4nr05982d.
2
Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules.平衡冠状物对脂质纳米胶囊治疗功效和巨噬细胞摄取的影响。
Biomaterials. 2015 Aug;61:266-78. doi: 10.1016/j.biomaterials.2015.04.049. Epub 2015 May 13.
3
Soft and Hard Interactions between Polystyrene Nanoplastics and Human Serum Albumin Protein Corona.聚苯乙烯纳米塑料与人类血清白蛋白蛋白冠之间的软硬相互作用。
Bioconjug Chem. 2019 Apr 17;30(4):1067-1076. doi: 10.1021/acs.bioconjchem.9b00015. Epub 2019 Mar 19.
4
In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.荧光相关光谱法原位表征蛋白质在纳米颗粒上的吸附。
Acc Chem Res. 2017 Feb 21;50(2):387-395. doi: 10.1021/acs.accounts.6b00579. Epub 2017 Feb 1.
5
Probing the binding affinity of plasma proteins adsorbed on Au nanoparticles.探测吸附在金纳米粒子上的血浆蛋白的结合亲和力。
Nanoscale. 2017 Apr 6;9(14):4787-4792. doi: 10.1039/c7nr01523b.
6
Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.基于碳水化合物的纳米载体,具有特定的细胞靶向性,受蛋白冠的影响最小。
Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7436-40. doi: 10.1002/anie.201502398. Epub 2015 May 4.
7
How Corona Formation Impacts Nanomaterials as Drug Carriers.新冠病毒如何影响纳米材料作为药物载体。
Mol Pharm. 2020 Mar 2;17(3):725-737. doi: 10.1021/acs.molpharmaceut.9b01111. Epub 2020 Jan 24.
8
Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.在不同的流场中保持软蛋白冠可以识别弱结合蛋白。
Acta Biomater. 2018 Aug;76:217-224. doi: 10.1016/j.actbio.2018.05.057. Epub 2018 Jun 8.
9
Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials.生物纳米界面特性及纳米材料冠状层外部相互作用的绘图。
Nanoscale. 2015 Oct 7;7(37):15268-76. doi: 10.1039/c5nr01970b.
10
Surface sulfonates lock serum albumin into a "hard" corona.表面磺酸盐将血清白蛋白锁定在“硬” corona 中。
Biomater Sci. 2019 Aug 1;7(8):3213-3225. doi: 10.1039/c9bm00475k. Epub 2019 Jun 3.

引用本文的文献

1
The Challenges and Opportunities of Protein Coronas for Nanoscale Biomolecular Sensing.蛋白质冠层在纳米级生物分子传感中的挑战与机遇
Small. 2025 Sep;21(36):e03820. doi: 10.1002/smll.202503820. Epub 2025 Jul 26.
2
The Protein Corona Paradox: Challenges in Achieving True Biomimetics in Nanomedicines.蛋白质冠层悖论:纳米药物中实现真正仿生学面临的挑战。
Biomimetics (Basel). 2025 Apr 29;10(5):276. doi: 10.3390/biomimetics10050276.
3
Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform.
空间链状富含氨基酸的水溶性碳量子点作为一种强大的肿瘤靶向药物递送平台。
Nat Commun. 2025 Mar 19;16(1):2716. doi: 10.1038/s41467-025-57531-0.
4
Evaluating the In Situ Effects of Whole Protein Coronas on the Biosensing of Antibody-Immobilized Nanoparticles Using Two-Color Fluorescence Nanoparticle Tracking Analysis.使用双色荧光纳米颗粒跟踪分析评估全蛋白冠层对抗体固定化纳米颗粒生物传感的原位效应。
Nanomaterials (Basel). 2025 Jan 30;15(3):220. doi: 10.3390/nano15030220.
5
Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles.糖聚合物纳米粒子比聚乙二醇化纳米粒子富集免疫原性较低的蛋白冠,减少单核吞噬细胞清除,提高肿瘤递呈。
ACS Nano. 2024 Nov 5;18(44):30540-30560. doi: 10.1021/acsnano.4c08922. Epub 2024 Oct 22.
6
Protocols for isolation and characterization of nanoparticle biomolecular corona complexes.纳米颗粒生物分子冠冕复合物的分离与表征方案。
Front Toxicol. 2024 Jul 23;6:1393330. doi: 10.3389/ftox.2024.1393330. eCollection 2024.
7
Deposition of Human-Serum-Albumin-Functionalized Spheroidal Particles on Abiotic Surfaces: Reference Kinetic Results for Bioparticles.球形人血清白蛋白功能化粒子在非生物表面上的沉积:生物粒子的参考动力学结果。
Molecules. 2024 Jul 20;29(14):3405. doi: 10.3390/molecules29143405.
8
Concepts and Approaches to Reduce or Avoid Protein Corona Formation on Nanoparticles: Challenges and Opportunities.减少或避免纳米颗粒蛋白冠形成的概念和方法:挑战与机遇。
Adv Sci (Weinh). 2024 Sep;11(34):e2402935. doi: 10.1002/advs.202402935. Epub 2024 Jul 8.
9
Performance of nanoparticles for biomedical applications: The / discrepancy.纳米颗粒在生物医学应用中的性能:差异
Biophys Rev (Melville). 2022 Feb 1;3(1):011303. doi: 10.1063/5.0073494. eCollection 2022 Mar.
10
Development of a New Affinity Gold Polymer Membrane with Immobilized Protein A.一种固定化蛋白A的新型亲和金聚合物膜的研制。
Membranes (Basel). 2024 Jan 24;14(2):31. doi: 10.3390/membranes14020031.